Focus Taiwan App
Download

Taiwan approves remdesivir as COVID-19 medication

05/30/2020 04:34 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taipei, May 30 (CNA) Taiwan's health authorities have approved the potential new coronavirus COVID-19 medication remdesivir for treatment of the disease in the country, the Central Epidemic Command Center said Saturday.


(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

    We value your privacy.
    Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.
    172.30.142.241